Blood Clots Clinical Trials
A listing of Blood Clots medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 199 clinical trials
A Phase 3b, Prospective, Open-label, Multicenter, Single Treatment Arm, Continuation Study of the Safety and Efficacy of TAK-755 (rADAMTS13, Also Known as BAX 930/SHP655) in the Prophylactic and On-demand Treatment of Subjects With Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP; Upshaw-Schulman Syndrome, or Hereditary Thrombotic Thrombocytopenic Purpura)
Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich
- 10 views
- 24 Oct, 2022
- 9 locations
A Multicentre, Prospective, Open-label, Uncontrolled Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events (TEEs) in patients with congenital antithrombin deficiency under cover of Atenativ for surgical
- 0 views
- 13 Oct, 2022
- 5 locations
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a rare disease that results in low levels of platelets - the cells that help blood clot. The main aim of the study is to check for side effects
- 3 views
- 07 Oct, 2022
- 8 locations
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19 (ACTIV-4A)
This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic and additional strategies for prevention of adverse outcomes in COVID-19 positive inpatients
- 287 views
- 25 Oct, 2022
- 100 locations
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (MAYARI)
plasma exchange (TPE) with primary endpoint of remission in male and female participants aged 18 to 80 years with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The anticipated study
- 1 views
- 24 Jan, 2023
- 2 locations
Randomized Study of Bailout Intracranial Angioplasty for Unsuccessful Thrombectomy (ANGEL-REBOOT)
multiple randomized controlled trials (RCT). Possible reasons of failed recanalization included technical failure of access, failure of retrieving thrombus, thrombotic re-occlusion, and pre-existing
- 0 views
- 04 Oct, 2022
- 1 location
Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT
biosimilar in the treatment of unresectable hepatocellular carcinoma with portal vein tumor thrombus.
- 0 views
- 07 Oct, 2022
- 1 location
Efficacy of Regenerative Endodontic Treatment With PRF as a Secondary Treatment of Mature Necrotic Incisors in Adolescents (PRF)
be treated with regenerative endodontic treatment(RET) with platelets rich fibrin PRF as intervention group vs. 20 incisors control group secondary treated with (RET) with induced blood clot (BC
- 0 views
- 07 Oct, 2022
- 2 locations
Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis
compared to standard treatment (blood clot; control group, n=20). Clinical and patient related outcome parameters will be recorded for up to 14 days after treatment. A more stable blood clot and thus
- 0 views
- 07 Oct, 2022
- 1 location
PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease (POINT-NOCAD)
, plaque erosion with thrombosis, vasospasm, embolization, dissection or a combination of mechanisms. Other patients may have clinically unrecognized myocarditis, or takotsubo syndrome masquerading as MI
- 0 views
- 04 Oct, 2022
- 1 location